Fig. 5.
Correlation between progression-free survival on first-line VEGF-targeted therapy and progression-free survival on second-line VEGF-targeted therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.